ASRT
|
Assertio Therapeutics, Inc.
|
US
|
NASDAQ
|
BIIB
|
Biogen Idec Inc.
|
US
|
NASDAQ
|
BLRX
|
BioLineRx Ltd.
|
US
|
NASDAQ
|
CNCE
|
Concert Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
ELYM
|
Eliem Therapeutics, Inc
|
US
|
NASDAQ
|
NKTR
|
Nektar Therapeutics
|
US
|
NASDAQ
|
RVNC
|
Revance Therapeutics, Inc.
|
US
|
NASDAQ
|
XENE
|
Xenon Pharmaceuticals Inc.
|
US
|
NASDAQ
|
ZYNE
|
Zynerba Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
BIEI
|
Premier Biomedical
|
US
|
OTC
|
CTTC
|
Calmare Therapeutics Incorporated
|
US
|
OTC
|
GBLX
|
GB Sciences, Inc
|
US
|
OTC
|
OCTHF
|
Oxford Cannabinoid Technologies Holdings Plc
|
US
|
OTC
|
RGEDF
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
|
US
|
OTC
|
SGIOF
|
Shionogi & Co Ltd
|
US
|
OTC
|
SGIOY
|
Shionogi & Co Ltd Un
|
US
|
OTC
|
TBPMF
|
Tetra Bio-Pharma Inc.
|
US
|
OTC
|
OCTP
|
Oxford Cannabinoid Technologies Holdings Plc
|
UK
|
LSE
|
OKYO
|
Okyo Pharma Corporation
|
UK
|
LSE
|
0IL
|
Intelgenx Technologs
|
DE
|
F
|